Researchers at Massachusetts Eye and Ear developed a preclinical research proof of concept that shows mRNA-based therapies ...

vectors with enhanced photoreceptor targeting for retinal gene therapy. Localization and distribution of Müller glia cells (CRALBP, red) in retinal organoids. Nuclear DAPI staining (blue).

The global macular degeneration treatment market is poised for significant growth, projected to expand from USD 9.1 billion ...

We can already tinker with human DNA to treat diseases. But being able to edit RNA allows for even more precision – and fewer ...

Key findings include reduced lesion growth, retinal tissue preservation, and improved visual function, demonstrating ...

A team of UC Davis Health researchers has shown that CD34+ stem cells can be safely administered into retinitis pigmentosa ...

It was a mother’s instinct and fierce determination that helped to save the sight of Melbourne schoolboy Krisshiv.

US FDA grants Orphan Drug Designation to AAVantgarde Bio’s AAVB-081 to treat Usher Syndrome Type 1B retinitis pigmentosa: Milan, Italy Tuesday, December 3, 2024, 16:00 Hrs [IST] ...

Francesca Simonelli Session title: Multicentric longitudinal study in Usher Syndrome IB: disease course and implication for gene therapy Session: Inherited retinal diseases treatments About the ...

This research evaluates the effects of various gene therapy viral vectors on RPE cells to determine efficacy for therapeutic ...

Detailed price information for Adverum Biotechnologies Inc (ADVM-Q) from The Globe and Mail including charting and trades.